down arrow

Sapporo Clinical Laboratory, Inc.

  • Market Cap: Micro Cap
  • Industry: Retailing
  • ISIN: JP3321100004
JPY
1,966.00
4 (0.2%)

Dec 11

TKS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
20,131.37
19,682.32
20,127.69
19,109.60
17,502.54
17,659.08
17,065.60
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
20,131.37
19,682.32
20,127.69
19,109.60
17,502.54
17,659.08
17,065.60
Raw Material Cost
14,176.93
13,959.53
14,001.60
12,933.20
11,878.70
12,255.47
11,994.14
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.68
7.49
8.17
9.03
2.58
2.17
1.60
Selling and Distribution Expenses
4,607.57
4,550.44
4,477.80
4,069.24
3,903.22
3,896.52
3,775.19
Other Expenses
0.11
0.20
0.11
0.18
0.57
0.71
0.81
Total Expenditure (Excl Depreciation)
18,792.24
18,519.43
18,488.62
17,013.28
15,790.17
16,161.29
15,779.01
Operating Profit (PBDIT) excl Other Income
1339.1
1162.9
1639.1
2096.3
1712.4
1497.8
1286.6
Other Income
9.03
-19.15
84.45
71.39
47.20
15.60
86.91
Operating Profit (PBDIT)
1,273.78
1,050.95
1,617.29
2,155.62
1,460.82
1,206.29
1,210.95
Interest
6.68
7.49
8.17
9.03
2.58
2.17
1.60
Exceptional Items
-8.64
90.08
-130.32
-97.45
-11.05
-114.12
-82.56
Gross Profit (PBDT)
5,954.44
5,722.78
6,126.09
6,176.40
5,623.84
5,403.62
5,071.46
Depreciation
558.67
535.59
519.10
547.00
271.27
244.73
308.63
Profit Before Tax
699.78
597.95
959.70
1,502.14
1,175.93
845.26
818.16
Tax
241.77
235.00
319.15
455.60
382.24
317.05
294.86
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
464.18
380.16
568.62
1,042.88
793.69
528.20
523.30
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
464.18
380.16
568.62
1,042.88
793.69
528.20
523.30
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-6.17
-17.20
71.93
3.66
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
458.01
362.95
640.55
1,046.54
793.69
528.20
523.30
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
11,153.90
10,936.65
10,585.40
10,114.30
9,272.38
8,463.15
7,981.38
Earnings per share (EPS)
148.39
114.16
170.55
306.19
231.87
154.31
152.43
Diluted Earnings per share
148.39
114.16
170.55
306.19
231.87
154.31
152.43
Operating Profit Margin (Excl OI)
3.51%
2.72%
5.04%
8.04%
6.53%
5.36%
4.78%
Gross Profit Margin
6.25%
5.76%
7.35%
10.72%
8.27%
6.17%
6.6%
PAT Margin
2.31%
1.93%
2.83%
5.46%
4.53%
2.99%
3.07%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 2.28% vs -2.21% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 26.17% vs -43.33% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 18.19% vs -30.19% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -10.67% vs -8.54% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Sapporo Clinical Laboratory, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
20,131.37
48,393.49
-28,262.12
-58.40%
Other Operating Income
0.00
0.00
0.00
Total Operating income
20,131.37
48,393.49
-28,262.12
-58.40%
Raw Material Cost
14,176.93
42,787.68
-28,610.75
-66.87%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
6.68
63.85
-57.17
-89.54%
Selling and Distribution Expenses
4,607.57
3,623.73
983.84
27.15%
Other Expenses
0.11
-6.38
6.49
101.72%
Total Expenditure (Excl Depreciation)
18,792.24
46,411.41
-27,619.17
-59.51%
Operating Profit (PBDIT) excl Other Income
1,339.13
1,982.08
-642.95
-32.44%
Other Income
9.03
380.89
-371.86
-97.63%
Operating Profit (PBDIT)
1,273.78
2,836.32
-1,562.54
-55.09%
Interest
6.68
63.85
-57.17
-89.54%
Exceptional Items
-8.64
-107.47
98.83
91.96%
Gross Profit (PBDT)
5,954.44
5,605.81
348.63
6.22%
Depreciation
558.67
763.41
-204.74
-26.82%
Profit Before Tax
699.78
1,901.59
-1,201.81
-63.20%
Tax
241.77
754.47
-512.70
-67.95%
Provisions and contingencies
0
0
0.00
Profit After Tax
464.18
1,133.17
-668.99
-59.04%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
464.18
1,133.17
-668.99
-59.04%
Share in Profit of Associates
0
0
0.00
Minority Interest
-6.17
13.95
-20.12
-144.23%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
458.01
1,147.12
-689.11
-60.07%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
11,153.90
14,097.86
-2,943.96
-20.88%
Earnings per share (EPS)
148.39
301.35
-152.96
-50.76%
Diluted Earnings per share
148.39
301.35
-152.96
-50.76%
Operating Profit Margin (Excl OI)
3.51%
3.50%
0.00
0.01%
Gross Profit Margin
6.25%
5.51%
0.00
0.74%
PAT Margin
2.31%
2.34%
0.00
-0.03%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 2,013.14 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 2.28% vs -2.21% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 45.80 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 26.17% vs -43.33% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 126.48 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 18.19% vs -30.19% in Mar 2024

Annual - Interest
Interest 0.67 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -10.67% vs -8.54% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.51%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."